Opana Buyers Want Pay-For-Delay Trial Split In 3
By Nadia Dreid · February 28, 2022, 4:59 PM EST
Buyers who say they overpaid for the prescription painkiller Opana ER want their pay-for-delay fight with Endo Pharmaceuticals and Impax Laboratories sliced into three separate trials, the buyers told an Illinois...
To view the full article, register now.